BALDINI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 23.072
AS - Asia 18.166
EU - Europa 14.431
SA - Sud America 1.137
Continente sconosciuto - Info sul continente non disponibili 1.052
AF - Africa 972
OC - Oceania 65
Totale 58.895
Nazione #
US - Stati Uniti d'America 22.487
CN - Cina 5.503
SG - Singapore 4.818
VN - Vietnam 3.694
GB - Regno Unito 3.333
IT - Italia 2.714
DE - Germania 2.226
HK - Hong Kong 1.263
SE - Svezia 1.239
FR - Francia 963
UA - Ucraina 917
IN - India 851
BR - Brasile 744
RU - Federazione Russa 727
NL - Olanda 515
KR - Corea 497
IE - Irlanda 465
JP - Giappone 415
CA - Canada 384
ZA - Sudafrica 337
FI - Finlandia 269
BD - Bangladesh 247
CI - Costa d'Avorio 246
EE - Estonia 209
AR - Argentina 165
SC - Seychelles 146
TG - Togo 142
CH - Svizzera 137
AT - Austria 131
ID - Indonesia 123
BG - Bulgaria 105
JO - Giordania 96
PH - Filippine 94
BE - Belgio 76
MX - Messico 70
PK - Pakistan 66
ES - Italia 65
PL - Polonia 65
IQ - Iraq 64
TR - Turchia 62
GR - Grecia 61
AU - Australia 59
TH - Thailandia 59
TW - Taiwan 58
IL - Israele 54
EC - Ecuador 53
CO - Colombia 52
LT - Lituania 35
MY - Malesia 35
HR - Croazia 33
SA - Arabia Saudita 33
CL - Cile 31
VE - Venezuela 30
UZ - Uzbekistan 29
PT - Portogallo 27
RO - Romania 26
PE - Perù 24
HN - Honduras 22
PY - Paraguay 22
EG - Egitto 21
MA - Marocco 19
CR - Costa Rica 18
IR - Iran 16
JM - Giamaica 16
LB - Libano 16
CZ - Repubblica Ceca 15
NI - Nicaragua 13
NO - Norvegia 13
AL - Albania 12
KE - Kenya 12
NG - Nigeria 12
AE - Emirati Arabi Uniti 11
HU - Ungheria 11
DO - Repubblica Dominicana 10
GT - Guatemala 10
NP - Nepal 9
PR - Porto Rico 9
UY - Uruguay 9
DK - Danimarca 8
OM - Oman 8
QA - Qatar 8
SK - Slovacchia (Repubblica Slovacca) 8
BO - Bolivia 7
KZ - Kazakistan 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BB - Barbados 6
DZ - Algeria 6
ET - Etiopia 6
MD - Moldavia 6
PS - Palestinian Territory 6
SV - El Salvador 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
SI - Slovenia 5
AM - Armenia 4
AO - Angola 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
PA - Panama 4
Totale 57.795
Città #
Singapore 3.354
Southend 2.568
Ashburn 2.072
Fairfield 1.752
Chandler 1.313
Santa Clara 1.181
Hefei 1.175
Hong Kong 1.125
San Jose 1.070
Houston 946
Woodbridge 868
Ann Arbor 848
Wilmington 816
Seattle 804
Ho Chi Minh City 780
Council Bluffs 705
Hanoi 705
Princeton 676
Jacksonville 654
Beijing 609
Cambridge 607
Los Angeles 507
Boardman 472
Dong Ket 472
Dublin 456
Seoul 435
Bologna 389
Tokyo 369
Lauterbourg 340
Nanjing 319
Dallas 286
Frankfurt am Main 281
Westminster 278
Padova 262
Abidjan 246
Berlin 229
Milan 205
Helsinki 204
New York 200
Buffalo 175
Chicago 153
Munich 151
Jinan 144
Lomé 142
Saint Petersburg 139
Shenyang 127
Guangzhou 125
San Diego 124
Shanghai 120
Mülheim 119
Bengaluru 118
Da Nang 115
Medford 111
Tianjin 108
Bern 107
Haiphong 105
Johannesburg 98
Sofia 97
Amman 96
Phoenix 93
Nanchang 92
Redondo Beach 92
Changsha 88
Boston 87
Hebei 85
Rome 83
Vienna 81
Montréal 78
Turin 78
Mcallen 77
Mahé 75
Zhengzhou 69
Hangzhou 68
São Paulo 68
Brussels 67
Florence 67
Toronto 67
San Francisco 66
Des Moines 64
Jakarta 62
London 62
Ottawa 62
Atlanta 61
Norwalk 60
Orem 53
Wuhan 52
Redmond 50
Jiaxing 49
Nuremberg 49
Bremen 48
Brooklyn 46
Amsterdam 45
Denver 45
Verona 45
Dearborn 43
Washington 43
Yubileyny 43
Modena 42
Warsaw 42
Paris 41
Totale 35.640
Nome #
The human tumor microbiome is composed of tumor type-specific intracellular bacteria 2.637
Validation of Suitable Housekeeping Genes for the Normalization of mRNA Expression for Studying Tumor Acidosis 580
Stem Cells 385
Cellule staminali 349
Potassium Citrate Supplementation Decreases the Biochemical Markers of Bone Loss in a Group of Osteopenic Women: The Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Study 349
Questionario di indagine sull’applicazione delle linee guida per la prevenzione delle complicanze del piede diabetico nel territorio emiliano 329
V-ATPase is a candidate therapeutic target for Ewing sarcoma 289
Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions 288
A natural biogenic fluorapatite as a new biomaterial for orthopedics and dentistry: antibacterial activity of lingula seashell and its use for nanostructured biomimetic coatings 287
Abstract 5909: IDH mutations in G2-3 conventional chondrosarcoma of bone: a mono institutional experience 276
In vitro biodegradation and osteoconductivity of poly(epsilon-caprolactone)/apatite scaffolds for bone repair. 267
A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. 264
V-ATPase as an effective therapeutic target for sarcomas. 257
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 254
Antibacterial and Antibiofilm Activity of Nanostructured Copper Films Prepared by Ionized Jet Deposition 253
Auto-Allo Graft Parallel Juxtaposition for Improved Neuroregeneration in Peripheral Nerve Reconstruction Based on Acellular Nerve Allografts 239
Exosomes: novel effectors of human platelet lysate activity. 235
Campi operatori in chirurgia ortopedica 234
Design and Rapid Manufacturing of a customized foot orthosis: a first methodological study 234
Exosome-like Nanovesicles Isolated from Citrus limon L. Exert Antioxidative Effect 234
Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone 234
Customized biofilm device for antibiofilm and antibacterial screening of newly developed nanostructured silver and zinc coatings 233
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 233
Institutional changes and the commercialization of academic knowledge: a study of Italian universities’ patenting activities between 1965 and 2002 227
Alpha-lipoic Acid After Median Nerve Decompression at the Carpal Tunnel: A Randomized Controlled Trial 226
Bone on-a-chip: a 3D dendritic network in a screening platform for osteocyte-targeted drugs 224
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience 223
Ionized jet deposition of antimicrobial and stem cell friendly silver-substituted tricalcium phosphate nanocoatings on titanium alloy 220
Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis 220
Strawberry-derived exosome-like nanoparticles prevent oxidative stress in human mesenchymal stromal cells 219
In vitro blockade of Receptor Activator of Nuclear factor kappa b ligand prevents osteoclastogenesis induced by neuroblastoma cells 218
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate 218
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. 218
Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation 216
Uncovering the protective role of lipid droplet accumulation against acid-induced oxidative stress and cell death in osteosarcoma 212
A novel technique for decellularization of allogenic nerves and in vivo study of their use for peripheral nerve reconstruction 211
Cause and effect of microenvironmental acidosis on bone metastases 209
New strontium-based coatings show activity against pathogenic bacteria in spine infection 206
Validation of a Cleanroom Compliant Sonication-Based Decellularization Technique: A New Concept in Nerve Allograft Production 206
Alumina and ultra-high molecular weight polyethylene particles differently influence osteoblast-osteoclast interactions 206
Ionized jet deposition of silver nanostructured coatings: Assessment of chemico-physical and biological behavior for application in orthopedics 205
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective 205
Prominent role of RAB39A-RXRB axis in cancer development and stemness 204
Incorporation/Enrichment of 3D Bioprinted Constructs by Biomimetic Nanoparticles: Tuning Printability and Cell Behavior in Bone Models 203
Biomimetica di polimeri per ingegneria tissutale dell'osso 203
The Combined Use of Mesenchymal Stromal Cells and Scaffolds for Bone Repair 203
Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus. 202
Diagnosis of infection after total hip replacement. 200
Ionized Jet Deposition of Calcium Phosphates-Based Nanocoatings: Tuning Coating Properties and Cell Behavior by Target Composition and Substrate Heating 199
The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells 199
Applicazioni cliniche della ricerca ortopedica 198
Introduzione alla diagnostica per immagini in ortopedia e traumatologia 196
Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression 196
Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts. 194
Foot Orthosis and Sensorized House Slipper by 3D Printing 193
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 193
Identification and validation of housekeeping genes for gene expression analysis of cancer stem cells 192
Noncellular Modification of Acellular Nerve Allografts for Peripheral Nerve Reconstruction: A Systematic Critical Review of the Animal Literature 192
Cell-Enhanced Acellular Nerve Allografts for Peripheral Nerve Reconstruction: A Systematic Review and a Meta-Analysis of the Literature 192
Intra-individual variability in the neuroprotective and promyelinating properties of conditioned culture medium obtained from human adipose mesenchymal stromal cells 191
MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: A new rationale for the pathogenesis of osteolytic bone metastases 190
New advances in the study of bone tumors: A lesson from the 3D environment 190
Endogenous extracellular matrix regulates the response of osteosarcoma 3D spheroids to doxorubicin 189
Is wear debris responsible for failure in alumina-on-alumina implants? 189
Contribution of mitochondrial activity to doxorubicin-resistance in osteosarcoma cells 188
Diffusion of Organisational Practices in Turbulent Environments: An Empirical Analysis of University-Level Patent Regulations 188
Tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion 188
Plasma levels of platelet-derived growth factor BB and transforming growth factor in patients with failed hip prostheses. 188
Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Cancer Metabolism 187
Biological basis for the use of autologous bone marrow stromal cells in the treatment of congenital pseudarthrosis of the tibia 187
FGF-2 effects on the osteogenic commitment of bone marrow stromal cells 185
To patent or not to patent? A survey of Italian inventors on motivations, incentives, and obstacles to university patenting 185
Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD. 185
Exploring metabolic adaptations to the acidic microenvironment of osteosarcoma cells unveils sphingosine 1-phosphate as a valuable therapeutic target 185
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells. 184
Cell-based Assay System for Predicting Bone Regeneration in Patient Affected by Aseptic Nonunion and Treated with Platelet Rich Fibrin 184
Nanodecoration of electrospun polymeric fibers with nanostructured silver coatings by ionized jet deposition for antibacterial tissues 184
Innovative silicate-based cements for endodontics: a study of osteoblast-like cell response 183
The effect of extracellular acidosis on the behaviour of mesenchymal stem cells in vitro 183
A natural multifunction and multiscale hierarchical matrix as a drug-eluting scaffold for biomedical applications 182
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. 182
A comparison of hemiarthroplasty with a novel polycarbonate-urethane acetabular component for displaced intracapsular fractures of the femoral neck: A randomised controlled trial in elderly patients. 182
A prospective, randomised, controlled trial using a Mg-hydroxyapatite - demineralized bone matrix nanocomposite in tibial osteotomy. 182
Does chronic raise of metal ion levels induce oxidative DNA damage and hypoxia-like response in patients with metal-on-metal hip resurfacing? 182
3d printing and bioprinting to model bone cancer: The role of materials and nanoscale cues in directing cell behavior 182
FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles 181
To patent or not to patent? A Survey of Italian inventors on motivations, incentives and obstacles to university patenting 181
Histogenetic characterization of giant cell tumor of bone 181
Spheroid-based 3D cell cultures identify salinomycin as a promising drug for the treatment of chondrosarcoma 181
The Effects of Systemic and Local Acidosis on Insulin Resistance and Signaling 181
Acid microenvironment in bone sarcomas 181
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles 180
In vitro blockade activator of nuclear factor-kappa B ligand prevents osteoclast differentiation induced by neuroblastoma cells 179
The performance of poly-ε-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4 179
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. 179
A regenerative approach for bone repair in congenital pseudarthrosis of the tibia associated or not associated with type 1 neurofibromatosis: correlation between laboratory findings and clinical outcome. 179
Do Ion Levels In Hip Resurfacing Differ From Metal-on-metal THA at Midterm? 179
Repurposing of Loperamide as a New Drug With Anticancer Activity for Human Osteosarcoma 178
In vitro study of human osteoclast activity on poli(epsilon-caprolactone) as a bone substitute biomaterial 178
Metal ion release from fracture fixation devices: a potential marker of implant failure. 178
Totale 23.908
Categoria #
all - tutte 157.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.159 0 0 406 463 479 330 151 408 189 628 1.060 1.045
2022/20235.969 646 823 312 713 465 440 216 338 975 152 523 366
2023/20241.614 144 297 125 120 137 220 84 97 66 152 92 80
2024/20257.662 244 1.135 627 518 1.478 461 398 217 92 553 401 1.538
2025/202619.450 1.541 1.908 1.758 1.520 2.310 1.197 1.767 881 3.515 1.476 787 790
2026/20273.196 911 877 1.408 0 0 0 0 0 0 0 0 0
Totale 58.895